The autosomal recessive disorder is primarily caused by mutations in the TGM5 gene and less frequently in the CSTA gene.
Susan Taylor, MD, FAAD, discusses how an individual can select a sunscreen as well as barriers to using them.
Physicians have a role in stamping out weight bias.
Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.
Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, highlight treatment options for a specific patient with AD, focusing on dupilumab.
Jack Arbiser, MD, PhD conducted research in a recent study to observe the impact R-propranolol has on broad-spectrum anti-coronavirus activity.
Epidermolysis bullosa is a broad term used to identify a group of genetic disorders that result in skin blistering and fragility.
Your practice’s finances are the key to long-term business success and understanding them doesn’t have to feel like a puzzle.
Golda explains why he prefers using tranexamic acid to control bleeding in granulated wounds.
As we continue to face the COVID-19 pandemic and its long-term consequences, it is more important than ever for providers to build trust with patients.
Fixed-annuity guarantees more income for penalty-free early withdrawals from retirement plans.
Harnessing digital marketing tools can help your medical practice grow.
Immunotherapy agent nemvaleukin alfa was granted an FDA fast track designation for the treatment of patient’s mucosal melanoma for previously undergone treatment with an anti-PD-L1 therapy.
Gold encourages all attendees to feel welcome as they attend both cosmetic and medical dermatology sessions.
It effects most teenagers and can lead to mental distress. Here are 5 important facts about acne vulgaris in adolescents.
Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
An expert in dermatology shares his thoughts on the educational and unmet needs in the identification and management of patients with GPP.
Joshua Zeichner, MD, delivered a boot camp on isotretinoin use at AAD 2023, including an overview of newer formulations of the acne drug that could help counter the common absorption challenges.
There are more than 355,000 nurse practitioners licensed in the United States in a variety of practice areas.
A new study showed about half of all vitiligo patients from a care system were burdened with the sleeping disorder.
A new allergen, acetophenone azine with generalized autoeczematization, is the cause of “shin guard dermatitis.”
Some adverse reactions to cosmetic procedures occur more often in patients with darker skin types. Patients should be counseled on appropriate cosmetic procedures for their skin type, according to Cheryl M. Burgess, M.D., at the Skin of Color Update virtual meeting.